Aristotle University Of Thessaloniki (AUTH)
Μελέτη της έκφρασης των ενζύμων και ομάδας γονιδίων που εμπλέκονται στο μεταβολισμό φαρμάκων και ξενοβιοτικών ουσιών σε όγκους εγκεφάλου
Abstract
dc:descriptionWe set out to study the expression profile of various genes and their respective proteins that are related to drug metabolism in human brain tumors. Brain tumor samples were collected only from newly diagnosed patients that hadn’t undergone previous radiation or chemotherapy. Using western blotting and quantitative real time PCR the protein and mRNA expression of aldehyde oxidase-1 (AOX1), glutathione-S-transferase (GSTs) -P, -T, M and cytochrome P450 1A1 (CYP1A1) were assessed. The gene expression profile of aldehyde dehydrogenase 3A1 (ALDH3A1) and cytochrome P450 1B1 (CYP1B1) were also evaluated. A total of 77 specimens were analyzed. We determined the expression of five proteins (CYP1A1, AOX1, GSTP, GSTT, and GSTM) in 54 surgical samples. We compared for any significant difference in the mean protein expression between meningiomas and astrocytomas. On average meningiomas expressed higher AOX1, GSTP and GSTM levels than astrocytomas (AOX: p=0,03, GSTP: p=0,009 and GSTM: p<0,001) but lower CYP1A1 levels (p=0,01). Correlation between the four degrees of malignancy (WHO I-IV) and the protein expression levels was evaluated. A significant negative correlation between malignancy grade and protein levels for AOX, GSTP and GSTM (p=0,002, p=0,004 and p=0,006 respectively) was reported. We also examined for any differences among the levels of the transcript product in a total of 47 tissue specimens. There were 20 meningiomas, 15 astrocytomas and 5 metastases. mRNA levels of CYP1B1, AOX1, GSTP1 and GSTM3 were significantly affected by the underlying pathology (p<0,05). Meningiomas had consistently higher mRNA levels than astrocytomas for the four abovementioned genes (UCYP1B1=33,5, p<0,001, UAOX1=14, p<0,001, UGSTP1=34, p<0,001 and UGSTM3=76,5, p=0,013). When comparing meningiomas with the metastasis group, the two genes that demonstrated the highest mRNA levels, namely AOX1 (M=12,81) and GSTM3 (M=7,89) retained their statistical significance in the difference between the two groups (UAOX1=5, p=0,001 and UGSTM3=8, p=0,002respectively). Lastly, the comparison among astrocytomas and adenocarcinomas only revealed a significant difference for the GSTP1 gene (UGSTP1=8, p=0,007). There was a significant negative correlation between malignancy grade and mRNA levels for AOX, GSTP1, GSTM3 and also for CYP1B1 (p=0,002, p=0,001, p=0,006 and p<0,001 respectively). For 32 samples, we were able to run both western and RT-PCR analysis. There is absolutely no correlation for any of the studied genes for the meningiomas group while there is one for AOX1 (p=0,011), GSTP1 (p=0,03), GSTM3 (p=0,02) in the astrocytomas group. We showed that the various CNS tumors show different patterns of drug metabolizing enzyme (DME) expression. Meningiomas exhibited significantly higher expression levels for the DMEs studied. For AOX1, GSTP and GSTM, this was shown on both a transcriptional and a translational level. For astrocytomas, we observed a correlation between mRNA levels and the translational product.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stavrinou, Pantelis
- Σταυρινού, Παντελής
Subjects
dc:subject × 20- S-τρανσφεράσες της γλουταθειόνης
- Αλδεϋδική δεϋδρογενάση
- Αλδεϋδική οξειδάση
- Ένζυμα κυτοχρώματος P450
- Όγκοι εγκεφάλου
- Μεταβολισμός
- Χημειοθεραπεία
- Φάρμακα
- Glutathione-S-transferase
- ALDEHYDE DEHYDROGENASE
- Aldehyde oxidase
- Cytochrome P450
- Brain tumors
- Metabolism
- Chemotherapy
- Drugs
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/33159